Mobile Tech Improving Cancer Treatment Decisions with Genomic Data

Our client, GenomeDx, is getting noticed, and rightfully so. Forbes contributor Robert Szczerba writes about how advancements in genomic tests/data are improving cancer treatment decisions and mobile apps’ place in genomic testing. Better decisions are directly improving the quality of care provided to patients. Congratulations, Andy Katz & Co!

We believe that merging genomic data with mobile technology will transform how doctors manage patient care in the clinic.

Read the entire Forbes article